Literature DB >> 22659130

De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1.

Anne-Laure Mahul-Mellier1, Christoph Datler, Evangelos Pazarentzos, Bevan Lin, Wanwisa Chaisaklert, Ghada Abuali, Stefan Grimm.   

Abstract

Dynamic ubiquitination impacts on the degradation of proteins by the proteasome as well as on their effects as signalling factors. Of the many cellular responses that are regulated by changes in ubiquitination, apoptosis has garnered special attention. We have found that USP2a and USP2c, two isoforms of the ubiquitin-specific protease USP2, cause cell death upon ectopic expression. We show that both USP2 isoforms can control the ubiquitination status of many proteins but from a panel of potential targets only the protein level of RIP1 was increased by these enzymes. This effect is responsible for the activity of USP2a and USP2c to cause cell death. Both enzymes likewise de-ubiquitinate TRAF2, a ubiquitin-ligase in the TNFR1 complex. Whilst this and the similar sub-cellular localisations of both enzyme isoforms indicate a substantial overlap of activities, inactivation by RNAi revealed that only the knock-down of USP2c resulted in apoptosis, whilst targeting USP2a did not have any consequence on the cells' survival. Consequently, we focussed our studies on USP2a and found that TRAF2 inhibits USP2a's effect on K48- but not on K63-linked ubiquitin chains. Hence, the ratio between USP2a and TRAF2 protein levels determines the cells' sensitivity to cell death.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659130     DOI: 10.1016/j.bbamcr.2012.05.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  The role of deubiquitinases in breast cancer.

Authors:  Zhenna Xiao; Peijing Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

2.  Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.

Authors:  Jongchan Kim; Fatemeh Alavi Naini; Yutong Sun; Li Ma
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

3.  Dysregulation and activities of ubiquitin specific peptidase 2b in the pathogenesis of hepatocellular carcinoma.

Authors:  Christina Nadolny; Xinmu Zhang; Qiwen Chen; Syed F Hashmi; Winifer Ali; Christopher Hemme; Nagib Ahsan; Yuan Chen; Ruitang Deng
Journal:  Am J Cancer Res       Date:  2021-10-15       Impact factor: 6.166

4.  The NAD-dependent deacetylase SIRT2 is required for programmed necrosis.

Authors:  Nisha Narayan; In Hye Lee; Ronen Borenstein; Junhui Sun; Renee Wong; Guang Tong; Maria M Fergusson; Jie Liu; Ilsa I Rovira; Hwei-Ling Cheng; Guanghui Wang; Marjan Gucek; David Lombard; Fredrick W Alt; Michael N Sack; Elizabeth Murphy; Liu Cao; Toren Finkel
Journal:  Nature       Date:  2012-11-28       Impact factor: 49.962

Review 5.  TGF-β signaling pathway mediated by deubiquitinating enzymes.

Authors:  Soo-Yeon Kim; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2018-10-22       Impact factor: 9.261

Review 6.  Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.

Authors:  Hae-Seul Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

7.  USP2a alters chemotherapeutic response by modulating redox.

Authors:  B Benassi; M Marani; M Loda; G Blandino
Journal:  Cell Death Dis       Date:  2013-09-26       Impact factor: 8.469

8.  Peroxisomal Import Reduces the Proapoptotic Activity of Deubiquitinating Enzyme USP2.

Authors:  Katharina Reglinski; Marina Keil; Sabrina Altendorf; Dominic Waithe; Christian Eggeling; Wolfgang Schliebs; Ralf Erdmann
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

Review 9.  Deubiquitinating enzymes as oncotargets.

Authors:  Urszula L McClurg; Craig N Robson
Journal:  Oncotarget       Date:  2015

Review 10.  The Molecular Mechanisms of Regulation on USP2's Alternative Splicing and the Significance of Its Products.

Authors:  Han-Qing Zhu; Feng-Hou Gao
Journal:  Int J Biol Sci       Date:  2017-11-02       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.